Pars compacta
(Redirected from Substantia nigra pars compacta)
Pars compacta is a portion of the substantia nigra, a basal ganglia structure located in the midbrain that plays a crucial role in reward, addiction, and movement. The pars compacta is one of the two parts of the substantia nigra, the other being the pars reticulata.
Structure[edit | edit source]
The pars compacta is characterized by its dense population of dopaminergic neurons. These neurons are responsible for producing dopamine, a neurotransmitter that plays a key role in the regulation of movement, mood, and reward. The neurons in the pars compacta send projections to the striatum, another part of the basal ganglia, where they release dopamine.
Function[edit | edit source]
The primary function of the pars compacta is the production and release of dopamine. This neurotransmitter is crucial for the normal functioning of the basal ganglia and the execution of smooth, coordinated movements. In addition to its role in movement, dopamine from the pars compacta also contributes to the reward system of the brain, influencing motivation, pleasure, and reinforcement learning.
Clinical significance[edit | edit source]
Damage or degeneration of the neurons in the pars compacta is associated with several neurological disorders. The most notable of these is Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the pars compacta. This loss leads to a decrease in striatal dopamine levels, resulting in the characteristic motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia.
Other conditions associated with the pars compacta include Schizophrenia, where there is thought to be an overactivity of the dopaminergic neurons, and drug addiction, where drugs of abuse can alter the function of these neurons and the release of dopamine.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD